Matches 1 - 50 out of 248 1 2 3 4 5 >
Match Document Document Title
US20090311799 Nucleic Acid Materials for Nonradiative Energy Transfer and Methods of Production and Use  
Nucleic acid materials for FRET-based luminescence and methods of making and using the nucleic acid materials are provided. The nucleic acid materials provide an innovative and synergistic...
US20090298066 Sex-Specific Marker for Shrimps and Prawns  
The present invention relates to a sex-specific marker for shrimps and prawns. More specifically, it relates to a sex-specific PCR-based molecular marker, derived from Penaeus monodon , that can...
US20090291906 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs  
Compounds, compositions and methods are provided for modulating the expression and function of small non-coding RNAs. The compositions comprise oligomeric compounds, targeted to small non-coding...
US20090292002 NUCLEOTIDE AND AMINO ACID SEQUENCES RELATING TO RESPIRATORY DISEASES AND OBESITY  
This invention relates to genes identified from human chromosome 12q23-qter, which are associated with various diseases, including asthma. The invention also relates to the nucleotide sequences of...
US20090286285 Modified Nucleic Acid Polymers and Methods for their Production  
The invention is directed to nucleic acid sequences having decreased thermodynamic stability to complementary sequence as well as a method for producing these sequences.
US20090281296 PROCESS FOR THE PRODUCTION OF CONJUGATES FROM POLYSACCHARIDES AND POLYNUCELOTIDES  
The present invention relates to a process for the production of a conjugate from a polynucleotide and a polysaccharide comprising the steps: a) provision of an aldonic acid of the polysaccharide...
US20090274681 NOVEL GENE ENCODING A DNA REPAIR ENZYME AND METHODS OF USE THEREOF  
An isolated nucleic acid molecule encoding a human DNA repair enzyme, MED1, is disclosed. Like other mismatch repair genes which are mutated in certain cancers, MED1, encoding nucleic acids,...
US20090275017 Novel Nucleoside or Nucleotide Derivative and Use Thereof  
The object of the present invention is to provide a nucleoside or nucleotide having a 5-substituted-2-oxo(1H)pyridin-3-yl group as a base, as well as a method using the same. In one embodiment,...
US20090269750 MARKER AND METHOD FOR CANCER DIAGNOSIS  
The present invention relates to a diagnostic cancer marker using variation of a granulocyte colony stimulating factor (G-CSF) gene and a method for preparing the same, and more specifically,...
US20090269814 Method of Analyzing a BRCA2 Gene in a Human Subject  
Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2...
US20090263900 Linear donor constructs for targeted integration  
Disclosed herein are linear donor molecules comprising homology arms of 50-750 base pairs (e.g., 50-100 base pairs) flanking one or more sequences of interest. The donor molecules and/or...
US20090263908 Liquid crystal condensation of nucleic acid (na) complexes  
Upon cooling solutions or melts of nucleic acids or other polymers in which the constituent molecules exhibit a varying tendency to form multi-strand complexes and thus liquid crystal phases, the...
US20090263413 IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND USE THEREOF IN PHARMACEUTICALS  
A novel immunostimulatory oligonucleotide by which an IFN-inducing activity is enhanced and an inflammatory cytokine-inducing activity is reduced, and a pharmaceutical containing the same, and an...
US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease  
The present invention relates to compositions and methods for preparing splice variants of TNFalpha receptor (TNFR) in vivo or in vitro, and the resulting TNFR protein variants. Such variants may...
US20090259030 STABILIZED NUCLEIC ACID DARK QUENCHER-FLUOROPHORE PROBES  
The present invention provides a new class of solids supports for synthesis of modified oligomers of nucleic acids, and nucleic acid probes that have a format expediently synthesized on the new...
US20090252828 ALPHA-AMYLASE VARIANTS WITH ALTERED PROPERTIES  
Disclosed are compositions comprising variants of alpha-amylase that have alpha-amylase activity and which exhibit altered properties relative to a parent AmyS-like alpha-amylase from which they...
US20090247610 INTEGRASE COFACTOR  
The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of...
US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)  
The present invention relates to methods for treatment of tumors and other diseases in a mammal comprising administration of antibodies specific for Macrophage-Stimulating Protein Receptor...
US20090239770 DETECTION OLIGOMER AND METHOD FOR CONTROLLING QUALITY OF BIOCHIP USING DETECTION OLIGOMER  
A detection oligomer and method for controlling the quality of a biochip using the detection oligomer are provided. The detection oligomer includes a template having a first and second end and...
US20090239220 DLC-1 GENE DELETED IN CANCERS  
A cDNA molecule corresponding to a newly discovered human gene is disclosed. The new gene, which is frequently deleted in liver cancer cells and cell lines, is called the DLC-1 gene. Because the...
US20090226571 Fermentative Production of Non-Volatile Microbial Metabolism Products in Solid Form  
The present invention relates to a method for the production of at least one nonvolatile microbial metabolite in solid form by sugar-based microbial fermentation, in which process a microorganism...
US20090226973 Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification  
An additive for preventing mispriming in polymerase chain reaction (PCR) amplifications and assays comprising a hairpin oligonucleotide having a stem duplex greater than six nucleotides in length...
US20090229016 CAMBIUM/XYLEM-PREFERRED PROMOTERS AND USES THEREOF  
The present invention related to nucleic acid molecules corresponding to regulatory portions of genes whose expression is predominant in cambium and/or xylem. The invention also relates to...
US20090221499 Lipidating Sequences and Use thereof for Producing Lipidated Proteins in E. Coli  
Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide.
US20090220966 THERMOCYCLER AND SAMPLE PORT  
The invention relates to continuous flow systems, in particular thermocyclers for the automated and continuous cycling of fluid between a plurality of temperature zones in the amplification of...
US20090221680 Aptamers that bind thrombin with high affinity  
The invention provides aptamers capable of binding to thrombin useful as therapeutics for and diagnostics of coagulation related disorders and/or other diseases or disorders in which thrombin has...
US20090215680 Inhibitor peptides  
The invention concerns peptides useful as MAP kinase/ERK pathway-specific inhibitors relative to a given substrate in a given subcellular compartment.
US20090215643 Highly Visible Chromosome-Specific Probes and Related Methods  
Disclosed are chromosome-specific synthetic oligonucleotides and labeled probe compositions, as well as related methods for preparing and using such compositions. Also disclosed are kits for...
US20090215635 LABELLING STRATEGIES FOR THE SENSITIVE DETECTION OF ANALYTES  
The present invention relates to methods and reagents for detecting analytes, e.g. nucleic acids. The new methods and reagents allow a simple and sensitive detection even in complex biological...
US20090215154 Method of preparing micro-and nanometric particles with labile Products  
The invention relates to a method of obtaining micro- and nanometric polymeric particles in a controlled, reproducible manner. The aforementioned particles have a spherical shape and a very narrow,...
US20090209747 METHOD TO INHIBIT CELL GROWTH USING OLIGONUCLEOTIDES  
Described are methods for treating hyperproliferative disorders, including cancers, by administering to the affected mammal (e.g., human) an effective amount of a composition comprising one or more...
US20090209751 METHODS AND KITS FOR EXTRACTION OF DNA  
Methods and materials are disclosed for use in recovering a biopolymer from a solution. In particular, the invention provides methods for extraction and isolation of nucleic acids from biological...
US20090202507 Intelligent Nanomedicine Integrating Diagnosis And Therapy  
A method of controlling the activity of a biologically active compound. The method concerns an oligonucleotide-based compound, comprising a hairpin-forming oligonucleotide, an effector moiety...
US20090203132 PYRROLIDINYL GROUPS FOR ATTACHING CONJUGATES TO OLIGOMERIC COMPOUNDS  
The present invention provides pyrrolidinyl compounds that are useful for preparing conjugated oligomeric compounds. The conjugated pyrrolidinyl compounds can be attached to support medium and...
US20090203572 Method for in Vitro Molecular Evolution of Protein Function  
The invention provides a method for generating a polynucleotide sequence or population of sequences from parent polynucleotide sequences, the method comprising the steps of (a) providing a first...
US20090197332 Modified Short Interfering RNA  
The present invention refers to a double-stranded siRNA molecule comprising a sense Strand and an antisense Strand which is essentially complementary to the sense Strand, each of the sense and the...
US20090191558 DETECTION, IDENTIFICATION AND DIFFERENTIATION OF SERRATIA SPECIES USING THE SPACER REGION  
The present invention relates to new nucleic acid sequences derived from the ITS (Internal Transcribed Spacer) region, between the 16S and 23S rRNA genes, to be used for the specific detection...
US20090192298 Through-bond energy transfer cassettes, systems and methods  
The present disclosure relates, according to some embodiments, to compositions, systems, and methods for preparing and using fluorescent through-bond energy transfer cassettes.
US20090185998 NEW ACTIVATED POLY(ETHYLENE GLYCOLS) AND RELATED POLYMERS AND THEIR APPLICATIONS  
There are disclosed chemically active poly(ethylene glycols) and other hydrophilic polymers that are suitable for coupling to pharmaceutically or diagnostically active agents such as peptides,...
US20090181916 LNA ANTAGONISTS TARGETING THE ANDROGEN RECEPTOR  
The invention relates to oligonucleotide compounds (oligomers), which target androgen receptor mRNA in a cell, leading to reduced expression of the androgen receptor. Reduction of androgen receptor...
US20090176968 Preparation of Triazole Containing Metal Chelating Agents  
New chelating agents as well as their tricarbonyl complexes with technetium and rhenium and the use of these compounds in radiodiagnosis and radiotherapy are described. As a peculiarity of this...
US20090176723 Methods and compositions involving miRNA and miRNA inhibitor molecules  
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns...
US20090163372 Nucleolipids and use thereof, and devices for nucleic acid analysis  
The invention relates to a method for isolating and/or identifying known or unknown, nucleic acid sequences (target sequences) which are marked, optionally, with reporter groups, by base specific...
US20090155795 BASELESS NUCLEOTIDE ANALOGUES AND USES THEREOF  
A method of detecting a target nucleic acid.
US20090148455 Anti-RANTES antibodies and methods of use thereof  
The invention relates to fully human monoclonal antibodies, and fragments thereof, that bind to the chemokine Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES, CCL5),...
US20090143529 Peptide purification by means of hard metal ion affinity chromatography  
A polymer substrate functionalized with a functionality comprising at least one cyclic, metal ion coordinating ligand group which comprises at least 3 nitrogen donor atoms in the ring of the cyclic...
US20090142748 MICROPOROUS MATERIALS, METHODS OF MAKING, USING, AND ARTICLES THEREOF  
Described herein are methods for separating one or more analytes present in a fluid sample. The methods involve passing the fluid through or into a microporous material, wherein the analytes are...
US20090136932 FIBERS WITH ISOLATED BIOMOLECULES AND USES THEREOF  
The present invention relates to compositions, methods, and uses for isolated biomolecule-containing fibers. The invention also relates to isolated, elongated biopolymers such as nucleic acids,...
US20090131648 Rigid dendrimeric structures  
The present invention provides novel dendrimers having a multimeric structure obtainable by reaction of a core molecule having an adamantoid structure with branching synthons and terminating...
US20090130752 BIODEGRADABLE POLY(DISULFIDE AMINE)S FOR GENE DELIVERY  
Poly(disulfide amine)s, methods of making, and methods of use are described. Illustrative embodiments of the poly(disulfide amine)s include poly(CBA-DAE), poly(CBA-DAB), and poly(CBA-DAH). These...
Matches 1 - 50 out of 248 1 2 3 4 5 >